Aerie Pharmaceuticals Analysis
| AERIDelisted Stock | USD 15.25 0.01 0.07% |
Aerie Pharmaceuticals is overvalued with Real Value of 12.92 and Hype Value of 15.25. The main objective of Aerie Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Aerie Pharmaceuticals is worth, separate from its market price. There are two main types of Aerie Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Aerie Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Aerie Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Aerie Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Aerie Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Aerie Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Aerie Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Aerie |
Aerie Stock Analysis Notes
About 98.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.47. Aerie Pharmaceuticals had not issued any dividends in recent years. Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina. Aerie Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 376 people. For more info on Aerie Pharmaceuticals please contact Vicente Anido at 919 237-5300 or go to www.aeriepharma.com.Aerie Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aerie Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aerie Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Aerie Pharmaceuticals is not yet fully synchronised with the market data | |
| Aerie Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 194.13 M. Net Loss for the year was (74.81 M) with profit before overhead, payroll, taxes, and interest of 167.29 M. | |
| Aerie Pharmaceuticals currently holds about 184.37 M in cash with (99.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.73. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies |
Aerie Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 753.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aerie Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Aerie Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Aerie Profitablity
Aerie Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Aerie Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Aerie Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Aerie Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Aerie Pharmaceuticals' profitability requires more research than a typical breakdown of Aerie Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.12.
About Aerie Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Aerie Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aerie shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Aerie Pharmaceuticals. By using and applying Aerie Stock analysis, traders can create a robust methodology for identifying Aerie entry and exit points for their positions.
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina. Aerie Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 376 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Aerie Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Aerie Stock
If you are still planning to invest in Aerie Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aerie Pharmaceuticals' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |